Glenmark Pharmaceuticals Inc., USA recalls Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Defective Delivery System: The dip tube is clogged causing the spray not to work.
- Products
-
- Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 45,504 bottles
- About this recall
- Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665 mcg/25 mcg per spray, 240 Metered Sprays/bottle, 29 g net fill weight, Distr. by Hikma Specialty USA Inc., Columbus, OH 43328, hikma, Glenmark Specialty SA. NDC 59467-700-27.